 hepatic renal transplantation primary hyperoxaluria type clinical report cases PURPOSE PATIENTS AND METHODS purpose article experience centers combined hepatic renal transplantation pyridoxine-resistant primary hyperoxaluria type alanine glyoxylate aminotransferase EC deficiency particular emphasis selection criteria timing operation Nine patients inherited disease combined hepatic renal transplantation former replaces enzyme-deficient organ latter affected organ RESULTS patient gross systemic oxalosis immediate postoperative period weeks generalized cytomegalovirus infection evidence biochemical correction patient severe osteodystrophy time operation months renal failure due progressive calcium oxalate nephrocalcinosis transplanted kidney thromboembolic disease extensive systemic oxalosis additional patient severe osteodystrophy months patient hyper-rejection kidney gastrointestinal hemorrhage long-term survivors months asymptomatic standpoint renal disease resolution manifestations systemic oxalosis employed education CONCLUSIONS prolonged period end-stage renal failure dialysis regimens suitable non-hyperoxaluric renal failure extensive systemic oxalosis oxalotic osteodystrophy poor prognostic features hepatic transplantation definitive treatment end-stage renal failure renal transplantation vigorous pre- perioperative hemodialysis body stores oxalate authorities hepatic transplantation patients renal transplantation liver kidney transplantation appropriate patients renal graft time hepatic transplantation irreversible renal damage patients